Furthermore, they suggested a possible prognostic value for CTC count and its associated vimentin expression (mesenchymal marker) in RCC patients due to a relevant association they found between these and RCC progression (including pathological stage) [63]. The gene discussed is VIM; the disease is renal cell carcinoma.